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Administration of TGF-{3, a fibrogenic inflammatory 
growth factor, proillotes fibrosis and scarring. Dexa-
lllethasone, an anti-inflamn"latory steroid, inhibits 
wound healing and reduces fibrosis. The current 
studies were initiated to determine whether the co-
administration of dexamethasone was able to abro-
gate the fibrogenic effect o fTGF-{3. Polyvinyl alcohol 
sponges were implanted subcutaneously on the ab-
dominal area of rats and directly injected with vehi-
cle, dexamethasone, TGF-{3, or dexamethasone plus 
TGF-{3. Dexamethasone was able to block the fibro-
genic effect of TGF-{3. Collagen and noncollagen 
p rotein synthesis was n"leasured as a function of 
TGF-{3 or dexamethasone concentrations in fibro-
blasts isolated fron"l granulation tissue. Addition of 
dexan"lethasone to cultures treated simultaneously 
with TGF-{3 blocked the fibrogenic response of 
TGF-{3. To study the molecular regulation of colla-
gen gene expression by TGF-{3 or dexaillethasone, 
fibroblasts derived from granulation tissue were sta-
T he ra te of coll agen synthesis is in creased in dermal wo unds compared with no rmal skin . T he increased ra te of co llagen syn thesis occurs as early as 24 h afte r wounding and con tinues over the next 5 d (Pulle r and C urron eo, 1992) . Both natural and syntheoc 
g lucocorticoids alte r co llagen metabo lism in n o rmal skin and 
during wo und healin g, whi ch resul ts in qua li tative and quantitative 
changes in the extrace llular m atrix of skin and in the skin \,vound-
healing processes (Goforth and G udas, 1980). G lu cocortico id trea t-
ment results in selective reductio n of co ll agen syn th esis (Newm an 
and C utro ll eo, 1978). 13eca usc the ga in in tensil e strength of an 
eady wo und is dependent on its coll agen content, treatment w ith 
glucoco rti coid resul ts in a decreased ga in in wou nd tensi le strength 
(Oxlund el ai, 1979) . Oxlund el al (1982), however , no ted a 
bip hasic efFect of g lu cocorticoid treatm enc o n in tact ra t skin: an 
initial increase in te nsil e stren g th associated w ith increased collagen 
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bly transfected with the ColCat 3.6 plasmid, which 
contains the rat proO'l(I) collagen promoter linked to 
the chloramphenicol acetyltransferase (CAT) gene. 
Dexamethasone decreased CAT activity whereas 
TGF-{3 increased the activity of this reporter gene. 
The increase in CAT activity observed with TGF-{3 
treatlDent was significantly decreased when dexa-
methasone was added to the cultures, although CAT 
activity did not return to control leve l. Since colJagen 
synthesis in fibroblasts treated simultaneously w ith 
dexarnethasone and TGF-{31 was found to be t h e 
sal1"le as that of untreated san"lples, the data indicate 
that there is a dexamethasone-n"lediated posttran-
scriptional regulation of proO'l(I) collagen mRNA. 
These studies demonstrate that at the ill vivo level, the 
cellular level, and the n"lolecular level, dexametha-
Sone is able to block the fibrogenic effect of TGF-{3. 
Kq wO/·ds: pl'Ocollagell/g/llcocO/·ticoid/wolllld repair. ] Itlllest 
Demlatol 108:285-289, 1997 
cross-linking fo Ll owed b y decreased coll agen synch esis resulting in 
decreased coll agen con ten t and thinner skin . A similar biphasic 
effect was reported by Vogel ( L 974). In addition, systemi c co rti co-
stero id treatlllent cau sed a decrease in coll agen conten t and a 
d ecrease in wo und tensile strength in derma l rat wounds (San dberg, 
1964). 
Transformin g growth f:lcto r-/3s (TGP-/3s) arc a g ro up of 
pol ypeptides th at stimubte the anch orage- independ eIH growth of 
nolltul11origeni <: ce ll s. TGF- /3 is secreted by most cultured cell s in 
th e inactive (l atent) fo rm . T here arc Illultiple isofonns, TGF-J3I , 2, 
and 3 that arc strua urally c losely re la ted to on e another. Afte r 
e ither secretio n fi 'om cells or re lease fi'om p late lets afte r injury. the 
la tent polypeptide is ' on verted to the active po lypeptide by pro-
teases (Lyons ci al. '1988; Sato and fUfkin , 1989). T he binding of the 
laten t polypeptide to a m ann o se-6-phosph ate receptor f:lcilitates 
the activatio n ofTGP-J3 by proteases in cludin g pla smin and cathep-
sin. O n ce activated, TGP-/3 binds to O';ll1sm embran serinelthreo-
nine killa se receptors (type I and typ ' II receptors) that arc 
respo nsibl ' to r signal transduction . D urin g wo und hea ling , TGP-J3 
stimula tes fi broblasts and o rhe r reparative ce ll s to synthes ize co lla-
gen (Ignotz an d Massagu c, 1986; Applin g c( al . 1989). 
In excisio nal wounds, TGP-{3 se lec tiv ely prol1lotes in crea sed 
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collage ll and m yo tl brobla sts (Pi e rce el (II , 199 1). III post-burn 
hype rtro phic scar tis su es, th e r e i s enhan ced exprcss ion o f mKN As 
fo r TG F-J3 and procolla ge ll s I and ILl (G hahary eI (/1 , 1993). 
Collagc n-matrix con t rac tio n is stimulated b y T GF-J3 (M o n tesan o 
,1I1d O rc i, 1988). TGF- J3 t re atm e nt a lso r esults in in c reased co ll age n 
syn th es is and co ll agen d e p os iti o ll in th e h e a lin g wOlLnd . A lth o ug h 
TG F-{3 m ay pla y a paramount ro le durin g the w o und-h ealin g 
process in te rms o f e n c han c in g w o und re pa ir , its ac ti o n o f pro m ot-
ing in c re ased co llagen synth es is lIl ay be resp o usibl e for subsequent 
d.i s fun c ti o n a l ti ssue ca u sed b y e xcessive scarring . 
W o und hea lin g is inhibited b y g lu coco rti coids alld stiml1late d by 
TGF-{3. C o administratio n o f TG F-{3 and g lu cocorti co id s ma y po -
tentia ll y pre ve nt excess scar fo rmati o n res ulting fi·om tre a tmen t 
with TG F-{3 a lon e . In this rega rd , TGF-J3 ha s be e n repo rte d to 
reverse g lu co co rti coid-induced impa ire d w o und h eaLin g ( Pi e rce et 
(II , 1 989; S lav in ct (II , ·1992 ; Beck et (/1 , 1993). G lucoconicoids arc 
anti-tibrotic and <l n ti-inAal11mato r y agents alld T GF-{3 is a fibroti c 
growth fa c tor (W a hl a nd W a hl, 1983). T h e fibrotic response to 
TGF-{3 tre atme nt may be pharmaco logicall y contro ll ed b y the 
addi tio n of t he prope r d ose o f g lu cocorti co ids, whic h arc se lective 
inhibito rs o f co llagen syn th es is . Pharl1l aco logica ll y contro llin g ex-
cess TGF-{3-indu ced co ll agc n synches is and d e p os itio n le adin g to 
excess scar fo nll ari o n has no t b ccn clea rl y define d and remain s a 
c h a Ue n ge . T h e CLlrrc llt study pro vid es a scie nrifi c r a ti o n a le for the 
u sc of a dual ph anna colog ic stra tegy to pre ve nt sca r formati o n a ll d 
impro ve th e quality of ti ssu e that is d e posite d in t h e w o und-he al in g 
proccss . III t h e c urrent stud y, the effec t of d exa m e th asone, TG F-{3, 
o r d ex ame th ason e pl u s TG F-J3 o n co llagen synth es is and proaJ (I) 
co lJa gen g cn e express io n wa s s tudi cd in po ly vin y l alco hol (PV A) 
sp o n gc impl ants and in fibro b lasts d e rived fro m g ranu la t io ll tissu e. 
M ATE1UALS ANI M.ETH ODS 
III Vi",) Gra nuloma Mode l Male Sprague-Dawley rats (Charles It iver 
Labm atorics . Wi lmington, MA ) (3 ·11 ::':: 2 g) were acclimated for 1 wk pri o r 
to surge ry. Dexam ethaso nc (1,4-pregnadien-9cr-fluoro- ·16(Y-llle thyl_ 
II {3, 17a,21-trio l-3 .20- dio ll c) was obta ined fro lll Steral oids (Wi lto n , NH) . 
Po rcin e TG F-{3 ·1 W:lS ob taill ed fro m It & 1) Systems (Minneapolis, MN). 
T he rats we re d iv ided ill to fo ur gro ups: CO lltro l, saLin e (n = 3), dexa lll e th-
asone aLo ne (n =. 4). TGF-{3 1 alo ne (n = 3), :lnd dexame th aso ne plus 
TG F-{31 (n = 3). R ats were ancSthe ti zed wi th KetasctH C I (Avcco. I' ort 
Dod ge, IA) ( 150 mg per rar) and sod iulTl pentob:lrbita l (A bbott Labo rato-
ri es, N o rth C hicago, IL) ( 100 IlIg per rat) . The abdomen was sh" ved , a 
la te r;d inc isio n \-vas made . al1d a subcutaneo ll s pock e t w as ll1adc with a 
fo n;c p . A 1lI0difi ed PV A spo nge di sc (Unipo ill t Industri es, High Point, N C) 
w ith a ll o u ts ide dia n 1C [ C r o f I 5 111111 a nd a ho le with a dj;'IJll c tc r of 5 n1l11 w as 
s;lIIdw iched between an o ute r surgicall y inerr and soft sili cone rubber di sc 
(Fisher Scientifi c, Fair LawlI , NJ) and an inert and hard po lye th ylene i,mer 
plasti c disc Uoshua Meie r, North Uergell. NJ) . This sand w ich was held 
toge the r by skin staples. T he Illodifi ed inlfJl ant was placed in the subcuta-
lI eo uS pocket. Each ilTlfJl ant was loca ted three in ches to ward til e neck regio n 
ullde r the skin w ith the soft silicone rubber disc fac ing the o uter abdonlell . 
Each im plall t rece ived 100 J.LI o f sa lill e, 100 J.LI o f dexamethasone (5 l.Lg). o r 
TG F-jl l (50 ng) ill sa.lillc. T he dexamethaso ne fJlu s TGF- {31 group was 
il~j ected with 50 p,l o f dexamethasone (5 JLg) alld 50 JLI o fTGF- (3 1 (50 ng) 
so lutio llS . The allimals were injected fo r 5 cOll secutive da ys wi tb 100 J.LI o f 
eac h so lutio n afte r w ithdrawing .I 00 JLI of w o ulld Auid fro m the r ese rvo ir of 
the implan t fo r the next 4 d after the ini tial injectio n . T he rats were 
sacrifi ced by excesS halothan e 3 d afte r tlt e las t injecti on " nd the imp lant WaS 
excised . T he irnplanr staples. silicone ru bber. alld pl"sti c di scs werc 
d iscarded. T he spo nge contailling tlt e g ranulatio ll t issue w as hydro lyzed in 
I ml of 6 N H C I for 24 h ar 120°C. Acti va ted charcoal N OI-it A (Fisher 
Scie nti fi c. Fa ir Lawn. NJ) W;I S added to cach sa rnfJl e , and the tubes were 
centrifu ged . A 50-JLI sa mple was used to anal yzc hydroxYfJro line as 
desc ribed (C urTo neo and COUllts. 1975) . 
Gr anulation Tissue F ibroblasts Fibro blasts deri ved fro m granulati on 
tiss ue we re es tabli shed f·i·nm o utgro wths of explants. Unmodified I'V A 
spo nges were placed subcutaneously in the dorsurn o f l11ale Sprague-
Dawley ra ts (200 - 250 g) . After 7 d , the anil11 als we re sacrifi ced alld the 
sp o n ges \ve rt.! rCIT1 0 VCC.:i. The sp o n ges we re placed in 1 UU-nl l11 ti ss lie culture 
di shes and overlaid with a steril e g lass slide and Dulbecco's mo diti ed Eagle's 
mediul11 (DMEM) sllfJplenl ented wi tb ·10% (v ol/vo l) fet;11 bo vin e Serum 
(H yclo ne. Logan, MT) and 100 units penicillin pcr 1111 and 100 l.Lg 
strcp tonl ycin per 1111 (GI.BCO .uru , Grand Island . NY) . O utgro wth o f 
T H E JOU RNAL O F IN VESTIGA TI VE DEltMATOLOGY 
fi broblasts was detecrcd w ithill 3 d. Th e m edium w as changed tw ice " 
week. alld after 2 wk tbe slides alld sponges were remo ved . The cell s were 
passaged by try psini zation and til e ce lls we re maintained ill DM EM (4.5 g 
g lucose pe r lite r; W hin.,kc r M .A . Oio prod uc ls. W:likc rsvill c. [V1D) cO l1 tai n -
ill g 10% (v o l/vo l) bca r- inactivare cl fe tal bov ill e senllll , ·100 uni ts pelli cillil) 
pc r ml , alld ·100 JLg strepto m yc il1 per 1111. Prio r to treallll e llt. th e ce lls were 
w"shed r\Vi ce w ith A IM V (G Ifj .0 13R..l., Gralld Islalld , N Y), a syl1theri c 
serullI - fi·ee lll ediulIl. T he ce ll we re trea ted witb T GF-{3 1 Or dex amethasone 
in AIM V medill ln . Lyophil ized samples nfTGF-/3 1 w ere rccOll slitured in .j 
111M H e l cOllrainill g I Ill g bov in e se rum albuillin pc r ltd befo re addiri on ro 
A IM V medium . T hi s so lurion W;1S added to con tro ls witho ul TG F-{31. 
C ellular CoUagen and Non collagen Protein Synthesis Fib ro blasts. 
at fJ assage nLlmbe r 5 Or G, we re pla ted at a density o f 1.2 to 1.4 X 10; cells 
pe r 25-cm 2 fla sk. Asco rbi c acid (Call3iocheln . Los Allge les. CAl at a fill al 
concentra tion of 16 I.LM was added d"il )' rn the cultures. The ce lls were 
treated with dex'"l1 cthasonc, T G F-{3 I, o r dexalll cr:ha so l1 e alld TG I' -{3 1 On 
dily 5 of c ulture . TWl; lIl Y fUlI r h o urs l,lLc r lilL" n: lb we n ; g ivc lI asco rbi c acid 
and 5-eHJpro line (20 JLCi/ nll o f medium ; 25 C ilrmn o l; Alll crsitam Li fe 
Scicll ces, Arl.ingron H eights, IL) fo r all additi o ll al 1.5 h . T he cell s were 
co ll ec ted by sc ropin g, washed w ith phosphare-buffe red sa lill e (G IIJCO 
Blt L) and cC lIlI·ifuged ar 1200 X ,~ to r 10 !"lIin . T hc cell s we re wash ed rwo 
;tddiliu ll a l t i_IlI CS w ilh phosph:lI:c-buffc red salill e all d rcs u ~ p c lJd c d ill -1.5 111 1 
o f 100 mM N aC I and 50 In M T ris(h yci ruxYITl c lhyl)alllino l1l c thane hydru-
chl o ride, pH 7.5. T he samples were hOl1l ogclli "cd ill a Po l)'tro ll ST 
hOl1l ogeni ze r (I1rinkmanll. Wes tbLlry. NY) fo r 45 s. bo iled Co r 10 mill. 
fo llowed by hOlllogenizatio n [o r 3() s. Ttadio acrive pro te in was diges ted 
w ith pll l-if-l ed bacterial co ll age nase (Ad vance l.li o li·acrurcs, Lynbrook, NY) 
to distingui sh co ll age n fro m IlOlIco li age n prote ill as described (Ne\V tr\ ;,n and 
C utro lleo, 1978) , 'lIId to tal protei.n leve ls we re detennill cd by the lIlethod 
of Lowry 1"1 ,,/ ( 195 1). 
Trallsfection of Granu lation T issue Fibroblasts and Stable Selec-
tion Ce ll s werc tr~lIl sfcc.tc d by using th e ca lc iulll phosphate copr(!cip ira-
tio ll m etho d (Che ll and Obyallla. 1987) . Plasln ids were fJurif·' ed by do uble 
Cs I banding acco rdin g to sta ndard l1I e tho ds. Co lC at 3.6 (sufJfJli ed by 
D . R.o we and A. Lich tler, Uni versil")' o f Connccti cllt H eal th Science Celller. 
Farmingto n. CT) co lltaining rhe rat procr I (J ) co Lla gen prollloter was 
translccted in to tibro blasts (Lichtl e r 1'1 ,,/ . 19S'i; R.i rze ntlzalcr 1"1 ,II , 199 1) . 
The pSV2neo plasmid w as cotrallsfccted in to ce ll s f·o r stable cd l selec ti on 
(Gonnan cl ai , 19R2; South ern and Berg. 1'i82). Ce ll s we re ,e lected with 
Ge ll eticin (200 JLg/ m l) . a lI eomyci ll anal og (G II3 CO BltL) . 
Preparation of Cell Lysates and A ssay of C hlOJ·amphel1licol Ace ty l-
transferase (CAT) Activity At the appropriate tint e afte r trC;ltl11ent. 
cell s were placed Oil icc . washed three tilll es w ith icc-cold phospha te-
bu lfered saline . and harvested ill I 1111 o f 40 111M T ri s(hr droxY111 eth yl)ami-
1I0 lTlc t.h anc h ydrochlo ride. pH 7.4. ISO 111M NaC I, I 111M eth ylenedi amine 
tetra :lcetic acid at 4° as described (G orman rI ai, 1982). CAT aClivit)" \Vas 
d c te nllill c.::.d by a 1l1 o di fll.:atiOIl o f all establi shed IIH!lho d (Nc ul11anll 1:1 tIl , 
1987). T he sam e alll 0Ulll of fJrotein was added to each reac rioll mix ture 
contained ill 50 J.LI o f 100 rllM T ris(h yd rox)' lll cth yl}amino lllcthall c hydro-
chl o ride . pH 7.8 . T wo hundred Ini cro lit e rs o f ·I .25 ITIM c1t.1 orarnphcnico l in 
·Ion rnM T riS(hydroxYlll cth yl)altlino llleth:l l1 c hyd rochlo ride, pH 7.8 , was 
added alo ng wi th 0.5 JLC i o f l' I-IJace tyl-CoA (200 m C i/ ltlnto l. DuPolH 
NE N. Bos ton . MA) "lid 22 .5 JLI o r1 111M ulliabeled acetyl-CoA (S igma. Sr. 
Lou is, MO). The entire rcac rio n rni x tufC wa~ overl aid with liquid scintil-
lati on fluid (Econo Au o r-2. DuPo nt N EN). This [l ssay all ows Illui tip le tim e 
po in t dc tcnninalio ns b y liquid scintiJ latio n cO llnrill g . The accty latcd chlo r-
amphellicol prod ll Cl: is miscible in th e aLJu eo us- illlllli scibl e scintiUarion 
Itli x [u rc. T irn c co urse ac ti vity or e ac h sanlp lc was d c re rl1li ll c d :llId onl y 
ac ti vit), ill the linear range o f the t inl !.! course w as used . \.V ithin cach assay , 
data fro 111 the Silln e [ il1ll~ po int w e n:! repo ned fo r nil sa l11p les. Pro rc iJl 
cO ll ce lltratio ns o f cell Iysates were de te rntin ed (Lowr)' "I II I. 195 1). 
Statisdcal Anal ysis All re sults : ... e ex pressed as rn C:III$ ::':: SEM . Signi fi-
cance or diifc n .! l1 ccs in m e ans w as derc nnined hy ~ tud e ll t ' s [ test. 
R E SULTS 
TGF-/31 Increascs Hydroxyprolinc Content in PVA Sponge 
lITlplants ·Wh e n d exa111eth<1 sone was administe re d dai ly tor 5 d 
a t a lo w d ose (5 /-Lg p e r spo n ge) , the hydroxypro lin e cO ll tc nt of th e 
PYA imp]ants wa s similar to sa line co ntro ls (Fig 1) . TGF-J31 at a 
high con centra tion (50 ng pe r sp o nge) caused a 2 .5-fo ld inc rease ill 
PV A sponge hydrox yprol in c conte nt. D cxa m e thason e whe n g ive n 
in combination with TGF-J31, bloc ke d the T GF-{3-induced in-
crease in hydroxyp ro line content in PV A spon g cs . T h e se data 
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F igure 1. Dexamethasone blocks the TGF-fl-illduced increase ill 
hydroxyproline content ill PYA implants. Sponges werc implanted 
and inj ected daily with saline, dex ,"lethasuJll: . TGF-{3 I . or dexamethasone 
p ills TGF-{3 J I'or 5 d. I~"ts were sae ril'iced 3 d after the last illjcction. and the 
sponges werc harvested and hydrol yzed in G N HC I for 24 h at 120°C . T he 
hydrox)'pro line CO li tent of the illlp lants are reported. En'or IIIII'S, SEM (n = 
3 or 4). ' Signi fi cantly d iflc rcm frolll con trol va lll cs at p < 0.05. 
s upport the h ypoth es is tha t coadministration of d examethasone and 
TGF-/3 blocks th e fib rogeni c effect ofTGF-/3. 
Dexamethasone Decreases Collagen Protein Sy nthesis in 
Rat Fibroblasts Derived from Granulation Tissue Dexa-
methason e t rea tm e nt of fib roblasts in culture resul ted in a se lective 
decrease of coll agen synth esis (F ig 2) . T h ere was a statistica lly 
significant dec rease in co ll agen prote in synth es is at 10 - 5 M and 
10 - 7 M dexa methasone, whereas th e re was no decrease in n o n co l-
lagen protein synthes is at less than 10 - r, M d exam ethason e . Col-
lagen synthesis wa s decreased b y 70'1., and 44% with 1 0 - 5 M and 
10 - 7 M dexametha sone, respectively, whereas noncollage n protein 
syn thesis was decreased b y 48% and O'y", respec tively. 
TGF-{31 Increases Collagen and NoncoUagen Protein Syn-
thesi s in Rat F ibroblasts D e rived from Granulation Tissue 
T he efFect of TGF-(31 o n coll agen protein syn th es is was nonspe-
200,----------------------------------, 
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100 
50 • 
o 10- 5 2 .5 x 10- 5 
Dexamethasone (M) 
Figure 2. Dexa m ethasone selectively decreases collagen protein 
synthesis in ra t fibroblasts. Rat fibrob lasts derived fi'o m granulation 
t issue wcrC grown to late logarithmic phase and exposed to 10- ", 10- 7 , 
10- 5 , o r 2 .5 X 10- 5 M dexamethasone for 24 h. Asco rbic acid and 
S-l'H]prolinc were added to cultures 1.5 h before harvesting cells. The cell s 
were co llected by scraping, and incorpo ration of ['H.lpro linc into collagcn 
and noneollagen protein was determined by collagenase digestion. 0 , 
Collagen protein synthesis; ~, nonco ll agen protein synthesis. Em Jr bars, 
SEM (n = 3). · Sign ifica ntl y different ti'om control va lues at p < 0.05. 
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Figure 3. TGF-fl1 significantly inc reases both collagen and n011-
collagen protein synthesis in r at fIbroblasts . Ra t fibrob lasts deri ved 
from g ranulation tissue werc grown to la tl! logarithmic phase and treated 
w ith TGF-fl1 at 0.5, 1.0,2 .5 , 5.0, or 10.0 ng/ml for 24 h. Ascorbic acid and 
5-[3H]pro linc were added to cultures 1.5 h before harvesting of cell s. T he 
cells were collected by scraping, and incorporation of C l-f lp roline in to 
co ll agen and nonco llagcn protein waS determined by co ll agenase digestion. 
O. Collagen protein syntll esis; ~. noncollagcn protein synthesis. Em)r bars, 
SEM (n = 3 to 5) . · Significa ntl y different [rom control va lues at p < 0.05 . 
c ifi c. TGF- /31 in c reased both co lJ agen and n o n collagen protein 
synthes is in a d ose-re lated mann er (Fig 3) . T h ere was an in c rease in 
collagen and n o n coll agen p!'Otein synthes is as the TGF-/31 co n cen-
tration increased reaching a maximum at 5.0 n g / ml. TGF- /31 at 2.5 
ng/ml produ ced a 2.1 - fo ld increase in both colJagen and n onco l-
lagen prote in synth es is. When fibrob lasts were treated w itb a 
combination of dexamethason e (10 - 6 M) and TGF-/31 (2.5 ng/ml), 
collagen and ll o n colJagen protein synth esis were at con tro l levels 
(Fig 4). T h us ill vitro studies sh owed th at dexamethason e b locked 
th e ftbrogen ic effect of TGF-/3 at th e cellular level. 
Dexa.methasone Decreases the TGF-{3-Induced Inc rease in 
Rat Pro O'(l) Collagen Promoter Activity ill Stably T r ans-
fected Fibroblasts To stu dy th e tr an scrip tio n al regula tion of 
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Figure 4. Collagen and nonc ollagell protein synthesis returns to 
c ontrol level w hen rat fibroblasts are treated witl1 dexamethasone 
and TGF-/31. l~at fibroblasts derived from granulation tiss ue were grown 
to late loga ri thmic phase and treated with 10- (' M dexa methasone. 2.5 ng 
TGF-{31 per ml, or 10- (' M dexamethasone plus 2.5 ng TGF-{31 per IlI l for 
24 h. Ascorbic acid and S[JH]proline were added to cultures 1.5 h befo re 
harvesting of ce ll s. The cell s were co ll ected by scraping, and incorporation 
of ['H]proline into collagen and nonco llagen protein was determined by 
collagcnase digestion. 0 , Collagen protcin s)"'thesis; ~, nonco llagcn 
protein synthes is. Em". bars, SEM (n = 4 or 5). · Significantl)' different fro lll 
control values at p < 0.05. 
288 MEISLER ET AL 
20 
N 
b 
15 
x • 
~ --f-
c: 
~ + • 0 10 
'- ---+--
CL 
0> 
~ 
E 5 a. 
~ 
0 
r---+---
• 
n 
Control Dex TGF-p1 Dex + TGF-p1 
Figure 5. Dexamethasone decreases and TGF-/31 increases rat 
proal(J) colJagen promoter activity in stable rat fibroblasts. Rat 
fibroblasts derived from gra nulation tissue and sta bly transfeeted with 
olCat 3 .6 were examined for responsiveness to dexarnethasone, TGF-{31, 
or dexamethasone plus TGF-/31. Late logarithmic cells were treated with 
'10- 6 M dexamethasone, 10 ng TGF-/31 per ml, or 10- (0 M dexamethasone 
plus 10 ng TGF-/31 per ml for 48 h . Contro l ce ll s and ceUs treated with 
dexamethasone received the vehicle (4 mM HCI with '1 mg bovine serum 
albumin per ml) used to dissolve TGF-/31. Cel l Iysates were prepared and 
assayed for protein content and CAT activ ity. ErrOl' Ii",,,, SEM (n = 3 to 5). 
"Signifi cantly diff'ercnt from control va lues at p < 0.01; t significanti.y 
dilferent fi'orn TGF-/3l va lues at p < 0.01. 
procollagen gene exp ression by dexamethasone and TGF-/31 , 
fibrob lasts were stably transfected w ith. ColCat 3.6, a p.!asmid that 
contains 3.6 kilobase pairs of 5'-flank:ing DNA of rat proal(J) 
collagen gene linked to the CAT reporte r gene. Cells were treated 
w ith dexa metha sone, TGF-/31 , or dexamethasone plus TGF-/31. At 
10 - 6 M dexamethasone, there was a 48% decrease in CAT activity, 
but in cells treated with TGF-/31 at 10 ng/mJ, there was a 230%1 
increase in promoter acti vi ty (Fig 5) . When cells were treated with 
dexamethasone (.1.0 - 6 M) plus TGF- /31 (10 ng/m.l) , there was a 
170% in crease in CAT activity (Fig 5) (maximal stim ulation of 
co llagen and noncolJagen protein synthesis was observed with 
TGF-/31 between 2.5 ng/ml and 10 ng/ml). Since the level of CAT 
activity did not reach contwl levels as observed with collagen and 
noncoUagen protein synthesis .! evels, a posttranscriptional m echa-
nism(s) is proposed to be in volved. In this regard , reports in the 
literature have demonstrated a g l.ucocorticoid-mediated destabili-
zation of type I proco lla gen mRNAs in hum an and rat skin 
fibroblasts (Hamalain en e/ nl, '1985; Raghow ef ai, '1986). 
DIS ussrON 
It is we I] known that corti costero ids inhibit wound hea ling and that 
TGF-/3 stimulates wound hea ling. The current study describcs a 
potential mcthod for red uced scarring in tiss ue repa ir where thc 
fibrogcn ic effect of an agonist (TGF-/3) is partially blocked by an 
effective amount of antagonist (dexamethasone) to normalize co l-
lagen syn thesis. T he antagonist reduces the agon.ist-mediated in-
crease of collagen syn thesis through enhan ced col lagen gene ex-
pression. 
The wo und-h ea l.ing process is initiated as a response to injury. 
T he interplay of severa l b iologic systems is respons ibl e for the 
repair process, w hich is cri tical for self-prcse rvatio n . T he bio logic 
systems include inflammation, angiogenes is, collagen synthesis, as 
well as depos ition and e pith e .! ization . Altho ugh tissue repair occurs 
without intervention, the acce le rati on of co.!hgen synthesis by an 
agonist may promote the replacem ent of functional healthy tissue 
with nonfi.ll1 ctional scar tiss ue. Ou r stu di es indi cate that by limiting 
excessivc co llagen synthesis and dcposition, the risk of excessive 
sca r formation ca n be diminished . 
Growth factors promote wound healin g by recru iting cell s to the 
injury site as well as in creasiJl g the expression of it variety of gencs, 
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including co lla gen . T hc growth £,ctor TGF-/3 incl·cases the expres-
sion of the proal (I) coLlagen gene (Ritzenthaler c/ ai, 1991) . 
M~rked increases in ml'tNA levels for proal (1) collagen, proal (III) 
colla gen , an d TGF-/31 were found in human hypertrophic scar 
(Ghaharyel aI, 1993). Peltonen e/ al (1991) re ported that TGF-/31 
protein and mRNA alo ng with type I and type VI co llagen gene 
expressio n were e '! evated in keloid scar. T hey speculated that 
TGF-/31 produced by neovascu lar endothelia l ceLIs stimu late adja-
cen t .fibrob lasts to express additiona'! TGF-/3l , as w ell as enh ance 
procollagen gene expressi.on. On the other hand, one way anti-
infl ammatory steroids, such as dexameth~sone, can restrict or abate 
the wound-healing process is by selective.!y decreasing collagen 
gene expressio n (Cockayne ef ai, 1986; Cockayne and C utroneo, 
1988; .Meis.lcr cl ai, 1995). Through th e phcnomenon of autoinduc-
tion , TGF-/31 activates its own ml'tNA expression ~nd thereby 
increases its own secretion . This effect is media ted by a cis 
e lem ent(s) in thc 5'-Ranking region of TG F-/3 genes (Kim e/ ai, 
1989) . Autoi.nduction through this cis e1emcnt(s) is m ediated by 
binding of the AP-l comp .! ex (Kim el ai, 1990) . Dexamethasone 
decreases TGF-/31 mRNA and TGF-/3 protei.n secretion (Shull c/ ai, 
1995, Meisler cl (/1, 1.995). T he decrease in latent TGF-/3 secretion 
res ults in a decrease of active TGF-/3 and a subseq uent decrease of 
co lJagcn gene expression. 
Altho ugh dexa m ethasone treatment of fibroblasts deriv ed fi'om 
granulation tissue decreased col lagen synth esis, this corticosteroid 
at 5 J.Lg per PV A sponge did not decrease the accumulation of 
hyd roxyprolin e . 1n addition, although glucocorticoids selectively 
decrease collagen synth esis ill lIillo and in ce lJ cu lture (Cutroneo, 
1993) , they have ~ Iso been shown to decrease coll agenase-directed 
co llagen degradation ill tissues (Koob e/ ai, 1974). TGF-/3 treatment 
offibrob '! asts results in a decrease of pro collagenase expression with 
a concomitant stimulation of the m eta Lloendoproteinase inhibitor 
and plasminogen activator inhibi tor (Overa lJ e/ ai, 1989). 
A bimodal therapy involving th e use of growth factors and 
anti-inflammatory steroids wiH hopefully promote wound healing 
without the concomitant excessive scarring by increased colJagen 
de position. Bimodal topica l therapy using a synthe tic corticoste-
roid, such as the glucocorti coid dexamethasone, and TGF-/31 , a 
growth £,ctor, will reduce collagen synthesis resu lting fi'om in-
creased e ndogenous growth £Ktor synthesis. This bimodal therapy 
may be used to enhance normal repair in situations such as 
second-degree burn injuries in young patients. Topical corticos te-
roid treatment results in a decrease in collagen synthesis and a delay 
in re-epithelial.ization in dermal wounds. Inhibition of wound 
closure has recentJy been observed b y TGF-/3 and/or dexametha-
sone in a feta l m o use limb organ culture mode .! (Ehrli ch e/ ai, 1996). 
Concurrentl y administering TGF-/3 with dexamethasone restored 
the deposition of connective tissue but not re-ep ith elialization . To 
usc TGF-/3 and dexameth;lsone as a bimodal therapy to enhance 
wo und heaJin g, the e'xact dosages need to be determined . Once the 
dermis has regenerated , re-ep ithe lia lizatio n could be enchanced by 
d iscon tinuing treatment. 
lYe Ih nllk Bo/III;e ScllIlI;/r jill' Ihe prcpnrnlioll (1/lhis III nil II scripl. Hi e Ihnllk Drs. 
D. [,oJ!. Roll''' ",ul )J. LichllcrJor c/elllal;lIg Ihe ColCal 3.6 plflslII;t/. These sl(ulies 
",ere slI[lJJOrlet/ by Nfl l;ollal IlIsl;lII les ,!/ I-Icnlrh Grnlll' A R 40154, GM4 1343-08, 
al/ll G M-20298. 
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